Japanese pharmaceutical stocks are surging to record levels, defying a broader market decline, as investors seek safety and growth prospects amid global economic uncertainty.
Buoyed by the Federal Reserves dovish stance on interest rates, Asian stocks climbed for a third straight session, even as geopolitical tensions and a strong yen introduced some volatility.
The Federal Reserves decision to lower interest rates marks a turning point in its fight against inflation, aiming to stimulate the economy while carefully managing public and market expectations.